Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01427296 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing
A Phase 4 study of Colon Cleansing, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,154
- Enrollment target
- 18
- Study locations
NCT01427296 is a Phase 4 study of Colon Cleansing that has completed, run by Bausch Health Americas. The registered enrollment target is 2,154 participants. The trial reports 18 study locations across 13 states.
The verdict
NCT01427296, a Phase 4 study of Colon Cleansing, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,154 participants
- Enrollment target
- 18
- Study locations
Study Summary
The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.
Conditions Studied
Interventions
- DRUG Polyethylene glycol
- DRUG Oral sodium phosphate solution
Study Locations (18)
North Carolina
- - Fayetteville
- - High Point
- - Raleigh
Georgia
- - Macon
- - Suwanee
New York
- - Great Neck
- - New York
Ohio
- - Cincinnati
- - Mentor
California
- - San Carlos
Connecticut
- - Bristol
Maryland
- - Hagerstown
Michigan
- - Wyoming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,154 participants |
| Start Date | 2011-09-16 |
| Est. Completion | 2014-12-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01427296
The ClinicalTrials.gov registry entry for NCT01427296 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 2,154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colon Cleansing appearing as the primary indexed condition, and to 2 interventions - of which Polyethylene glycol is the first listed.
NCT01427296 reports 18 study locations spanning 13 distinct geographic areas - top geographies include North Carolina, Georgia, New York.
Frequently Asked Questions
What is clinical trial NCT01427296 about?
NCT01427296 is a clinical study titled "Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing". The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.
What is the current status of trial NCT01427296?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,154 participants. The study started on 2011-09-16. Estimated completion is 2014-12-09.
What conditions does trial NCT01427296 study?
This clinical trial studies the following conditions: Colon Cleansing.
What interventions are being tested in trial NCT01427296?
The interventions under investigation include: Polyethylene glycol (DRUG), Oral sodium phosphate solution (DRUG).
Who is sponsoring clinical trial NCT01427296?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01427296 being conducted?
This trial has 18 study locations across California, Connecticut, Georgia, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cleansing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.